GENERAL
FDA Warns Novo Nordisk Over Unreported Ozempic, Wegovy Deaths
The FDA has issued a warning letter to Novo Nordisk, citing failures to report three patient deaths, including one suicide, linked to its popular drugs Ozempic and Wegovy. The agency highlighted delays in reporting and a lack of investigation into the suicide case. Novo Nordisk stated it is working diligently to address the FDA's concerns.